The DOI matches its Crossref record; 308 of the 308 references it cites were found in a registry or an index.
Acinetobacter baumannii : Emergence of a Successful Pathogen
Open accessAbstract
SUMMARY: Acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions globally. As a consequence of its immense ability to acquire or upregulate antibiotic drug resistance determinants, it has justifiably been propelled to the forefront of scientific attention. Apart from its predilection for the seriously ill within intensive care units, A. baumannii has more recently caused a range of infectious syndromes in military personnel injured in the Iraq and Afghanistan conflicts. This review details the significant advances that have been made in our understanding of this remarkable organism over the last 10 years, including current taxonomy and species identification, issues with susceptibility testing, mechanisms of antibiotic resistance, global epidemiology, clinical impact of infection, host-pathogen interactions, and infection control and therapeutic considerations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–308 of 308
Higgins, P. G., Wisplinghoff, H., Stefanik, D., & Seifert, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh427 · Cited by 120
Self-citationNosocomial Acinetobacter Meningitis Secondary to Invasive Procedures: Report of 25 Cases and Review
Siegman‐Igra, Y., bar-yosef, S., Gorea, A., & Avram, J. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.5.843 · Cited by 120
Koomanachai, P., Tiengrim, S., Kiratisin, P., & Thamlikitkul, V. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.09.011 · Cited by 119
Gu, B., Tong, M., WenJun, Z., Liu, G., Ning, M., Pan, S., & Zhao, W. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01318-06 · Cited by 118
Schaub, I. G., & Hauber, F. D. (1948) · Journal of Bacteriology · doi:10.1128/jb.56.4.379-385.1948 · Cited by 117
Donay, J., Mathieu, D., Fernandes, P., Prégermain, C., Bruel, P., Wargnier, A., Casin, I., Weill, F., Lagrange, P. H., & Herrmann, J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1542-1546.2004 · Cited by 117
Wisplinghoff, H., Schmitt, R., Wöhrmann, A., Stefanik, D., & Seifert, H. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.02.016 · Cited by 116
Self-citationSusceptibility of Acinetobacter Strains Isolated from Deployed U.S. Military Personnel
Hawley, J. S., Murray, C. K., Griffith, M. E., McElmeel, M. L., Fulcher, L. C., Hospenthal, D. R., & Jorgensen, J. H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00858-06 · Cited by 116
Sader, H. S., Jones, R. N., Stilwell, M. G., Dowzicky, M. J., & Fritsche, T. R. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.05.005 · Cited by 114
Bradford, P. A., Petersen, P. J., Young, M., Jones, C. H., Tischler, M., & O’Connell, J. F. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3903-3909.2005 · Cited by 113
Erridge, C., Moncayo-Nieto, O. L., Morgan, R., Young, M., & Poxton, I. R. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46823-0 · Cited by 112
Song, J. Y., Kee, S. Y., Hwang, I. S., Seo, Y. B., Jeong, H. W., Kim, W. J., & Cheong, H. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm136 · Cited by 112
Kuo, L.-C., Lai, C., Liao, C., Hsu, C.-K., Chang, Y.-L., Chang, C.-Y., & Hsueh, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01601.x · Cited by 110
VEB-1 Extended-Spectrum β-lactamase–producingAcinetobacter baumannii, France
Naas, T., Coignard, B., Carbonne, A., Blanckaert, K., Bajolet, O., Bernet, C., Verdeil, X., Astagneau, P., Desenclos, J., Nordmann, P., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1708.051547 · Cited by 110
Maragakis, L. L. (2004) · JAMA · doi:10.1001/jama.292.24.3006 · Cited by 109
Sader, H. S., Castanheira, M., Mendes, R. E., Toleman, M. A., Walsh, T. R., & Jones, R. N. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.08.013 · Cited by 108
The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica
Musa, E. H., Desai, N., & Casewell, M. W. (1990) · Journal of Hospital Infection · doi:10.1016/0195-6701(90)90029-n · Cited by 106
Siroy, A., Cosette, P., Seyer, D., Guillier, C., Vallenet, D., DORSSELAER, A. V., Boyer-Mariotte, S., Jouenne, T., & Dé, E. (2006) · Journal of Proteome Research · doi:10.1021/pr060372s · Cited by 106
Coelho, J., Woodford, N., Afzal-Shah, M., & Livermore, D. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.756-758.2006 · Cited by 104
Falagas, M. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl130 · Cited by 102
VIM-1 Metallo-β-lactamase inAcinetobacter baumannii
Tsakris, A., Ikonomidis, A., Pournaras, S., TZOUVELEKIS, L. S., Sofianou, D., Legakis, N. J., & Maniatis, A. N. (2006) · Emerging infectious diseases · doi:10.3201/eid1206.051097 · Cited by 101
Comparison of three standardized disc susceptibility testing methods for colistin
Tan, T. Y. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl330 · Cited by 100
Computer Keyboards as Reservoirs for Acinetobacter baumannii in a Burn Hospital
Neely, A. N., Maley, M. P., & Warden, G. D. (1999) · Clinical Infectious Diseases · doi:10.1086/313463 · Cited by 99
Jawad, A., Hawkey, P. M., Heritage, J. C., et al. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.10.2353-2358.1994 · Cited by 99
Houang, E. T. S., Chu, Y.-W., Lo, W. U., Chu, K. Y., & Cheng, A. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1382-1390.2003 · Cited by 99
Bacteria Recovered from Patients Admitted to a Deployed U.S. Military Hospital in Baghdad, Iraq
Yun, H. C., Murray, C. K., Roop, S. A., Hospenthal, D. R., Gourdine, E., & Dooley, D. P. (2006) · Military Medicine · doi:10.7205/milmed.171.9.821 · Cited by 98
Falagas, M. E., Kasiakou, S. K., Kofteridis, D. P., Roditakis, G., & Samonis, G. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0191-2 · Cited by 95
-Lactamase Inhibition and In Vitro Activity of Sulbactam and Sulbactam/Cefoperazone
Williams, J. D. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.494 · Cited by 95
Saballs, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl274 · Cited by 93
Dissemination of Acinetobacter baumannii Clones with OXA-23 Carbapenemase in Colombian Hospitals
Villegas, M. V., Kattán, J. N., Correa, A., Lolans, K., Guzmán, A. M., Woodford, N., Livermore, D. M., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00226-07 · Cited by 93
Identification of an OprD Homologue in Acinetobacter baumannii
Dupont, M., Pagès, J., Lafitte, D., Siroy, A., & Bollet, C. (2005) · Journal of Proteome Research · doi:10.1021/pr050143q · Cited by 92
Saugar, J. M., Rodríguez-Hernández, M. J., de la Torre, B. G., Pachón-Ibáñez, M. E., Fernández‐Reyes, M., Andreu, D., Pachón, J., & Rivas, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1251-1256.2006 · Cited by 91
Dijkshoorn, L., Brouwer, C. P. J. M., Bogaards, S. J. P., Nemec, A., van den Broek, P. J., & Nibbering, P. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4919-4921.2004 · Cited by 91
Ribera, A., Ruiz, J., de Anta, M. T. J., & Vilà, J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.4.697 · Cited by 91
Nemec, A., Maixnerová, M., van der Reijden, T. J. K., van den Broek, P. J., & Dijkshoorn, L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm231 · Cited by 91
Broad-Spectrum Peptide Inhibitors of Aminoglycoside Antibiotic Resistance Enzymes
Boehr, D. D., Draker, K.-A., Koteva, K. K., Bains, M., Hancock, R. E. W., & Wright, G. D. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00026-7 · Cited by 90
Attributable Mortality of Nosocomial Acinetobacter Bacteremia
Grupper, M., Sprecher, H., Mashiach, T., & Finkelstein, R. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/512629 · Cited by 90
Wolff, M., Joly‐Guillou, M., Farinotti, R., & Carbon, C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1406 · Cited by 90
Peterson, A. A., Fesik, S. W., & McGroarty, E. J. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.230 · Cited by 89
Waites, K. B., Duffy, L. B., & Dowzicky, M. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00210-06 · Cited by 89
Robenshtok, E., Paul, M., Leibovici, L., Fraser, A., Pitlik, S. D., Ostfeld, I., Samra, Z., Perez, S., Lev, B., & Weinberger, M. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.025 · Cited by 86
Holloway, K. P., Rouphael, N., Wells, J. B., King, M. D., & Blumberg, H. M. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h353 · Cited by 84
Targeting Bacterial Secretion Systems: Benefits of Disarmament in the Microcosm
Baron, C., & Coombes, B. K. (2007) · Infectious Disorders - Drug Targets · doi:10.2174/187152607780090685 · Cited by 82
Pereira, G. H., Müller, P. R., & Levin, A. S. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.01.008 · Cited by 81
Chan, P., Huang, L., Lin, H.-C., Chang, L., Chen, M., Lu, C., Lee, P., Chen, J.-M., Lee, C., Pan, H.-J., et al. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/513120 · Cited by 77
Penicillin-derived inhibitors that simultaneously target both metallo- and serine-β-lactamases
Buynak, J. D., Chen, H., Vogeti, L., Gadhachanda, V. R., Buchanan, C. A., Palzkill, T. G., Shaw, R. W., SPENCER, J. M., & Walsh, T. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.037 · Cited by 77
Pantopoulou, A., Giamarellos‐Bourboulis, E. J., Raftogannis, M., Τσαγανός, Θ., Dontas, I. A., Koutoukas, P., Baziaka, F., Giamarellou, H., & Perrea, D. N. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.09.009 · Cited by 77
Gant, V. A., Wren, M. W. D., Rollins, M. S. M., Jeanes, A., Hickok, S. S., & Hall, T. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm201 · Cited by 76
Immunisation in the current management of cystic fibrosis patients
Malfroot, A., Adam, G., Ciofu, O., Döring, G., Knoop, C., Lang, A. B., Damme, P. V., Dab, I., & Bush, A. (2005) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.10.003 · Cited by 76
Goel, V., & Kapil, A. (2001) · BMC Microbiology · doi:10.1186/1471-2180-1-16 · Cited by 75
Rodríguez-Hernández, M. J., Cuberos, L., Pichardo, C., Caballero, F. J., Moreno, I., Jiménez-Mejías, M. E., García-Curiel, A., & Pachón, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.479 · Cited by 74
Novel Resistance-Nodulation-Cell Division Efflux System AdeDE in Acinetobacter Genomic DNA Group 3
Chau, S.-L., Chu, Y.-W., & Houang, E. T. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.4054-4055.2004 · Cited by 73
O’Neill, E., Humphreys, H., Phillips, J., & Smyth, E. G. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki462 · Cited by 73
Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA)
Brenwald, N. P., & Fraise, A. P. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00222-6 · Cited by 71
Kasiakou, S. K., Rafailidis, P. I., Liaropoulos, K., & Falagas, M. E. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.05.008 · Cited by 70
Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997–2002
重敏, 森., Weinberger, M., Siegman-Igra, Y., Lazarovitch, T., Ostfeld, I., Boldur, I., Samra, Z., Shula, H., Carmeli, Y., Rubinovitch, B., et al. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.01.007 · Cited by 67
Detection and characterization of quorum sensing signal molecules in Acinetobacter strains
González, R. H., Nusblat, A. D., & Nudel, B. C. (2001) · Microbiological Research · doi:10.1016/s0944-5013(01)80004-5 · Cited by 67
Halstead, D. C., Abid, J., & Dowzicky, M. J. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.11.018 · Cited by 66
Completely Resistant Acinetobacter baumannii Strains
Mahgoub, S. M., Ahmed, J., & Glatt, A. E. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502091 · Cited by 66
Bacterial efflux pump inhibition.
Kaatz, G. W. (2005) · PubMed · Cited by 64
Chu, Y. W., Chau, S. L., & Houang, E. T. S. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46433-0 · Cited by 64
STEFANIUK, E. M., Baraniak, A., Gniadkowski, M., et al. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-0962-y · Cited by 64
Brink, A. J., Moolman, J., da Silva, M. C., & Botha, M. (2007) · PubMed · Cited by 64
Plasmid DNA Profiles of Acinetobacter Baumannii: Clinical Application in a Complex Endemic Setting
Seifert, H., Boullion, B., Schulze, A., & Pulverer, G. (1994) · Infection Control and Hospital Epidemiology · doi:10.2307/30148402 · Cited by 62
Self-citationGram-negative Bacillary Meningitis after Cranial Surgery or Trauma in Adults
Briggs, S. E., Ellis-Pegler, R. B., Raymond, N. J., Thomas, M., & Wilkinson, L. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410027193 · Cited by 62
Steward, C. D., Mohammed, J. M., Swenson, J. M., Stocker, S. A., Williams, P. P., Gaynes, R. P., McGowan, J. E., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.351-358.2003 · Cited by 62
Wisplinghoff, H., Hippler, C., Bartual, S. G., Haefs, C., Stefanik, D., Higgins, P. G., & Seifert, H. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02010.x · Cited by 61
Self-citationGoverman, J. M., Weber, J. M., Keaney, T. J., & Sheridan, R. L. (2007) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e318053d346 · Cited by 59
Conrad, R. S., & Galanos, C. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.10.1724 · Cited by 59
Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii
Feliu, A., Ruiz, J., & Vilà, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2310-2312.2003 · Cited by 59
Nosocomial meningitis in a university hospital between 1993 and 2002
Palabiyikoğlu, İ., Tekeli, E. İ., Cokca, F., Akan, Ö. A., Ünal, N., Erberktas, I., Lale, S., & KİRAZ, S. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.06.010 · Cited by 57
de Leon, G. P., Elowe, N. H., Koteva, K. K., Valvano, M. A., & Wright, G. D. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.02.010 · Cited by 56
Lee, A. M., Ross, C. T., Zeng, B.-B., & Singleton, S. F. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050113z · Cited by 55
AcinetobacterSkin Carriage Among US Army Soldiers Deployed in Iraq
Griffith, M. E., Lazarus, D. R., Mann, P. B., Boger, J. A., Hospenthal, D. R., & Murray, C. K. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/518966 · Cited by 55
Rhomberg, P. R., & Jones, R. N. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.07.009 · Cited by 53
Dorsey, C. W., Beglin, M. S., & Actis, L. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4188-4193.2003 · Cited by 53
Sulbactam: a beta-lactamase inhibitor.
Noguchi, J. K., & Gill, M. A. (1988) · PubMed · Cited by 50
Characterization of a high-affinity iron transport system in Acinetobacter baumannii
Echenique, J., Arienti, H. M., Tolmasky, M. E., Read, R. R., Staneloni, R. J., Crosa, J. H., & Actis, L. A. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.23.7670-7679.1992 · Cited by 47
Community-Acquired Acinetobacter baumannii Bacteremia in Adult Patients in Taiwan
Wang, J., McDonald, L. C., Chang, S., & Ho, M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1526-1529.2002 · Cited by 47
Falagas, M. E., & Kasiakou, S. K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00101-06 · Cited by 45
Heinemann, B., Wisplinghoff, H., Edmond, M. B., & Seifert, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2211-2213.2000 · Cited by 45
Self-citationManagement of the febrile neutropenic cancer patient: lessons from 40 years of study
Bow, E. J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01240.x · Cited by 44
Rapid Evolution of Diminished Transformability in Acinetobacter baylyi
Bacher, J. M., Metzgar, D., & de Crécy‐Lagard, V. (2006) · Journal of Bacteriology · doi:10.1128/jb.00846-06 · Cited by 43
Brauers, J., Frank, U., Kresken, M., Rodloff, A. C., & Seifert, H. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01015.x · Cited by 43
Self-citationPetersen, P. J., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3910-3918.2005 · Cited by 42
Jones, R. N., Anderegg, T. R., & Swenson, J. M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.925-927.2005 · Cited by 42
Validation and Reproducibility Assessment of Tigecycline MIC Determinations by Etest
Bolmström, A., Karlsson, A., Engelhardt, A., Ho, P., Petersen, P. J., Bradford, P. A., & Jones, C. H. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00089-07 · Cited by 41
[Studies of 26 strains of Moraxella Iwoffi].
Piéchaud, M., & Second, L. (1951) · PubMed · Cited by 41
Sader, H. S., & Jones, R. N. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.01.011 · Cited by 40
Joly‐Guillou, M., Decré, D., Herman, J. L., Bourdelier, E., & Bergogne-Bérézin, E. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.4.619 · Cited by 38
Joly‐Guillou, M., Wolff, M., Farinotti, R., Bryskier, A., & Carbon, C. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.827 · Cited by 38
Maslow, J. N., Glaze, T., Adams, P., & Lataillade, M. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502489 · Cited by 37
Menozzi, M. G., Eigner, U., Covan, S., Rossi, S., Somenzi, P., Dettori, G., Chezzi, C., & Fahr, A.-M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00614-06 · Cited by 36
Olut, A. I., & Erkek, E. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500262567 · Cited by 31
Shirawi, N., Memish, Z. A., Cherfan, A. J., & Shimemeri, A. A. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.5.554 · Cited by 29
Rhomberg, P. R., Fritsche, T. R., Sader, H. S., & Jones, R. N. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.10.010 · Cited by 26
Paramythiotou, E., Karakitsos, D., Aggelopoulou, H., Sioutos, P. J., Samonis, G., & Karabinis, A. (2007) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2006.11.011 · Cited by 26
Kroeger, L. A., Hovde, L. B., Mitropoulos, I. F., Schafer, J. A., & Rotschafer, J. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01433-06 · Cited by 26
Sader, H. S., Rhomberg, P. R., & Jones, R. N. (2005) · Journal of Chemotherapy · doi:10.1179/joc.2005.17.6.622 · Cited by 24
Tong, W., Wang, R., Chai, D., et al. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.008 · Cited by 21
Jung, R., Husain, M., Choi, M. K., & Fish, D. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.1055-1057.2004 · Cited by 20
Infection Control Challenges Related to War Wound Infections in the ICU Setting
Whitman, T. J. (2007) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e318065aa71 · Cited by 18
COMMUNITY‐ACQUIRED ACINETOBACTER PNEUMONIA
Gottlieb, T., & Barnes, D. J. (1989) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1989.tb00260.x · Cited by 18
Choi, S., Choo, E. J., Kwak, Y. G., et al. (2007) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0488-1 · Cited by 18
Prosthetic Valve Endocarditis Caused by Acinetobacter lwoffi
Starakis, I., Blikas, A., Siagris, D., Marangos, M. N., Karatza, C., & Bassaris, H. P. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000163801.67781.a2 · Cited by 16
Choi, S., Kim, M., Kim, M., et al. (2006) · Journal of Infection and Chemotherapy · doi:10.1016/s1341-321x(06)70898-4 · Cited by 11
Fetiye, K., Karadenizli, A., Okay, E., Oz, S., Budak, F., Gündeş, S., & Vahaboğlu, H. (2004) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-3-2 · Cited by 10
[Nosocomial infections caused by Acinetobacter: experience in a neonatal care unit in Casablanca].
Nejjari, N., Zerhouni, F., Bouharrou, A., Habzi, A., Najdi, T., Lahbabi, M., & Benomar, S. (2003) · PubMed · Cited by 4
Cited by
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
Cekanaviciute, E., Yoo, B. B., Runia, T. F., Debelius, J. W., Singh, S., Nelson, C. A., Kanner, R., Bencosme, Y., Lee, Y. K., Hauser, S. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711235114 · Cited by 1,036
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
Metadata
- Authors
- Peleg, A. Y., Seifert, H., & Paterson, D. L.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2008-07
- Volume
- 21
- Issue
- 3
- Pages
- 538-582
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2159435953
- Cited by
- 3,316
- References
- 308
- FWCI
- 50.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.